Treatment of Periodontitis by Conventional 4 Weekly Sections or Within 24 Hours
NCT02215460 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 130
Last updated 2014-08-13
Summary
Periodontitis is a form of gum disease that affects many people in the world. Its traditional protocol of treatment includes oral hygiene instruction and dental scaling to remove debris, dental plaque and tartar in 4 weekly sections. There is an additional time-reduced option also usually cheaper. In this last one, all above described procedures are performed within 24 hours. However, up to now comparative effectiveness between these both types of treatment is not well understood. For, example it is not clear if patients treated in the shorter-time experienced more pain. Therefore, the present study used several parameters to clarify whether beneficial differences between these therapeutic protocols exist or not. In addition, aspects that could help clinicians' and patient's decisions such as experience of pain and anxiety related to dental treatment were also investigated. After receiving verbal and written explanations and signed the informed consent form 150 individuals (n=15/group) having the most common type of periodontitis in adults were randomly allocated to be treated in 4 weekly sections or within 24 hours. Oral hygiene instructions and dental debridement were performed alone or in conjunction with antimicrobial agents: a mouth rinse containing chlorhexidine or systemic azithromycin antibiotic tablets. The parameters measured at baseline, 3, 6 and 9 months after treatment were: indicators of inflammation, amount of oral debris and malodor; quantification of bacteria in plaque samples collected with paper points from teeth and tongue; amount of produced saliva and self-reported questionnaires to collect information about oral condition, daily activities, pain and anxiety related to dental treatment.
Conditions
- Periodontitis
Interventions
- DRUG
-
FMS placebo rinse
Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 60-day use of placebo mouth rinse (15mL/30 seconds/ 2 times a day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
FMS azithromycin tablets
Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 3-day use of azithromycin tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
FMS placebo tablets
Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 3-day use of placebo tablets (1 tablet/day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
QS azithromycin tablets
Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 3-day use of azithromycin tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
QS placebo tablets
Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 3-day use of placebo tablets (1 tablet/day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- PROCEDURE
-
FMS full-mouth scaling
Participants received oral hygiene instructions and full-mouth scaling within 24 hours. Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- PROCEDURE
-
QS quadrant scaling
Participants received oral hygiene instructions and quadrant scaling in 4 weekly sections. Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
FMS chlorhexidine rinse
Participants received oral hygiene instructions and full-mouth scaling within 24 hours followed by a 60-day use of 0.12% chlorhexidine mouth rinse (15mL/30 seconds/ 2 times a day). Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
QS chlorhexidine rinse
Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 60-day use of 0.12% chlorhexidine mouth rinse (15mL/30 seconds/2 times a day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
- DRUG
-
QS placebo rinse
Participants received oral hygiene instructions and full-mouth scaling in 4 weekly sections followed by a 60-day use of 0.12% placebo mouth rinse (15mL/30 seconds/2 times a day). Debridement procedures were carried out Debridement procedures were carried out under local anesthesia with manual Gracey and McCall curettes and Hirschfield files.
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Taubate
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-04-30
- Primary Completion
- 2014-03-31
- Completion
- 2014-04-30
Countries
- Brazil
Study Locations
More Related Trials
-
Effect of Periodontitis Treatment on Quality of Life and Experiences of Fear, Anxiety and Pain
NCT02409966 ·Status: COMPLETED ·Phase: NA
-
Use of Ozone Gel as an Antimicrobial in Treatment of Periodontitis
NCT05905445 ·Status: COMPLETED ·Phase: PHASE1
-
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
NCT02197260 ·Status: COMPLETED ·Phase: PHASE4
-
Amoxicillin and Metronidazole in Association With Non-surgical Therapy in Aggressive Periodontitis Treatment
NCT03933501 ·Status: COMPLETED ·Phase: PHASE4
-
Local and Systemic Antimicrobials in Non-surgical Periodontal Therapy
NCT05608564 ·Status: COMPLETED ·Phase: NA
-
Amoxicillin and Metronidazole During or After the Periodontal Treatment
NCT06177119 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Azithromycin as an Adjunct to Scaling and Root Planning in the Treatment of Periodontitis
NCT05506371 ·Status: COMPLETED ·Phase: NA
-
Impact of Non-surgical Periodontal Therapy on Oral and Gut Microbiome
NCT04580355 ·Status: UNKNOWN ·Phase: PHASE4
-
Metformin Versus Chlorhexidine Gel as Adjuncts to Scaling and Root Planing in Stage II Grade B Periodontitis
NCT07215156 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.
NCT01906450 ·Status: UNKNOWN ·Phase: NA
-
Amoxicillin and Metronidazole During Periodontal Treatment
NCT02954393 ·Status: UNKNOWN ·Phase: NA
-
Impact of Periodontal Treatment on Serum Levels of Hepcidin and Hemoglobin
NCT02641210 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Subgingivally Delivered Doxycycline Plus Ketoprofen Gel as an Adjunct to Non-surgical Periodontal Treatment
NCT02538224 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Probiotic Use in Chronic Periodontitis Patients
NCT02403960 ·Status: COMPLETED ·Phase: NA
-
Effect of Ozone Gel on Treatment of Chronic Periodontitis
NCT02066337 ·Status: COMPLETED ·Phase: PHASE2
-
HA35 Treatment the Gingival Discomfort as Well as Gingival Redness and Bleeding of Patients With Periodontitis
NCT05765513 ·Status: COMPLETED ·Phase: NA
-
Acute-phase Response & Periodontal Treatment in Diabetes Affected Patients
NCT03087266 ·Status: COMPLETED ·Phase: NA
-
Treatment of Chronic Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy
NCT02734784 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients
NCT03783845 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers
NCT00066066 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Periodontal Therapy on Biomarkers in Periodontitis
NCT05005923 ·Status: COMPLETED ·Phase: NA
-
MTZ Plus AMX in the Treatment of Smokers and Non-smokers
NCT01837199 ·Status: COMPLETED ·Phase: PHASE4
-
Non-surgical Periodontal Therapy: Efficacy of re Treatment for Non-responding Sites.
NCT05297227 ·Status: UNKNOWN
-
Prevalence of Porphyromonas Gingivalis Fimbrial Subunit Genotype in Smokers and Nonsmokers After Periodontal Therapy
NCT02879903 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Nonsurgical Periodontal Therapy Verses Oral Hygiene Instructions on Patients With Chronic Periodontitis
NCT02208739 ·Status: COMPLETED ·Phase: NA